Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34+ cells and their transmigration through reconstituted basement membrane

Blood

Volumn 93, Issue 10, 1999, Pages 3379-3390

  Janowska Wieczorek, Anna ^a   Marquez, Leah A ^b   Nabholtz, Jean Marc ^b   Cabuhat, Maria L ^b   Montaño, Jencet ^b   Chang, Hung ^b   Rozmus, Jacob ^b   Russell, James A ^b   Edwards, Dylan R ^b   Turner, A Robert ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; CD34 ANTIGEN; COLONY STIMULATING FACTOR 1; CYTOKINE; ENZYME ANTIBODY; GELATINASE A; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 8; MATRIGEL; MATRIX METALLOPROTEINASE; STEM CELL FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BASEMENT MEMBRANE; BURST FORMING UNIT E; CELL MIGRATION; CELL SUBPOPULATION; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; MIGRATION INHIBITION; MOLECULAR DYNAMICS; MYELOPOIESIS; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0033562364     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.10.3379.410k09_3379_3390     Document Type: Article

References (54)

1. To LB, Haylock DN, Simmons PJ, Juttner CA: The biology and clinical uses of blood stem cells. Blood 89:2233, 1997
2. Simmons PJ, Leavesley DI, Levesque JP, Swart BW, Haylock DN, To LB, Ashman LK, Juttner CA: The mobilization of primitive hematopoietic progenitors into the peripheral blood, in Murphy MJ (ed): Polyfunctionality of Hemopoietic Regulators: The Metcalf Forum. Stem Cells 12:187, 1994 (suppl 1)
3. Papayannopoulou T, Priestley GV, Nakamoto B: Anti-VLA4/VCAM-1-induced mobilization requires cooperative signaling through the kit/mkit ligand pathway. Blood 91:2231, 1998
4. Goetzl EJ, Banda MJ, Leppert D: Matrix metalloproteinases in immunity. J Immunol 156:1, 1996
5. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA: Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 4:197, 1993
6. Stetler-Stevenson WG, Hewitt R, Corcoran M: Matrix metalloproteinases and tumor invasion: From correlation and causality to the clinic. Semin Cancer Biol 7:147, 1996
7. Chambers AF, Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89:1260, 1997
8. Van Wart HE, Birkedal-Hansen H: The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87:5578, 1990
9. Murphy G, Knaüper V: Relating matrix metalloproteinase structure to function: Why the "hemopexin" domain? Matrix Biol 15:511, 1997
10. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61, 1994
11. Knäuper V, Murphy G: Membrane-type matrix metalloproteinases and cell surface-associated activation cascades for matrix metalloproteinases, in Parks WC, Mecham RP (eds): Matrix Metalloproteinases. San Diego, CA, Academic, 1998, p 199
12. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP: Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur J Cell Biol 74:111, 1997
13. Janiak M, Hashmi HR, Janowska-Wieczorek A: Use of the Matrigel-based assay to measure the invasiveness of leukemic cells. Exp Hematol 22:559, 1994
14. Matsuzaki A, Janowska-Wieczorek A: Unstimulated human acute myelogenous leukemia blasts secrete matrix metalloproteinases. J Cancer Res Clin Oncol 123:100, 1997
15. Sawicki G, Matsuzaki A, Janowska-Wieczorek A: Expression of the active form of MMP-2 on the surface of leukemic cells accounts for their in vitro invasion. J Cancer Res Clin Oncol 124:245, 1998
16. Kossakowska AE, Hinek A, Edwards DR, Lim MS, Zhang C-L, Breitman DR, Prusinkiewicz C, Stabbler AL, Urbanski LS, Urbanski SJ: Proteolytic activity of human non-Hodgkin's lymphomas. Am J Pathol 152:565, 1998
17. Borregaard N, Cowland JB: Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89:3503, 1997
18. Hanlon WA, Stolk J, Davies P, Humes JL, Mumford R, Bonney RJ: rTNF-alpha facilitates human polymorphonuclear leukocyte adherence to fibrinogen matrices with mobilization of specific and tertiary but not azurophilic granule markers. J Leukoc Biol 50:43, 1991
19. Masure S, Proost P, Van Damme J, Opdenakker G: Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. Eur J Biochem 198:391, 1991
20. Welgus HG, Senior RM, Parks WC, Kahn AJ, Ley TJ, Shapiro SD, Campbell EJ: Neutral proteinase expression by human mononuclear phagocytes: A prominent role of cellular differentiation. Matrix Suppl 1:363, 1992
21. Saren P, Welgus HG, Kovanen PT: TNF-α and IL-1 selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 157:4159, 1996
22. Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL: T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 154:4379, 1995
23. Stetler-Stevenson WG, Krutzsch HC, Wacher MP, Margulies IMK, Liotta LA: The activation of human type IV collagenase proenzyme. J Biol Chem 264:1353, 1989
24. Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102:196, 1980
25. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239, 1987
26. Mayani H, Guilbert LJ, Clark SC, Janowska-Wieczorek A: Inhibition of hematopoiesis in normal human long-term marrow cultures treated with recombinant human macrophage colony-stimulating factor. Blood 78:651, 1991
27. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
28. Wong H, Anderson WD, Cheng T, Riabowol KY: Monitoring mRNA expression by polymerase chain reaction: the "primer-dropping" method. Anal Biochem 223:251, 1994
29. Sutherland DR, Keating A: The CD34 antigen: Structure, biology and potential clinical applications. J Hematother 1:115, 1992
30. Bender JG, Unverzagt KL, Walker DE, Lee W, Van Epps DE, Smith DH, Stewart CC, To, LB: Identification and comparison of CD34-positive cells and their subpopulation from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 77:2591, 1991
31. + hematopoietic progenitor cells: Comparison of cytokine mobilized blood stem cells with normal bone marrow. J Hematother 2:483, 1993
32. + cells mobilized into PB of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood 89: 1189, 1997
33. + peripheral blood progenitor cells mobilized by chemotherapy and granulocyte colony-stimulating factor. Blood 86:3500, 1995
34. Ries C, Petrides PE: Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem 375:345, 1995
35. Borden P, Heller RA: Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryotic Gene Expression 7:159, 1997
36. Johnatty RN, Taub DD, Reeder SP, Turcovski-Corrales SM, Cottam DW, Stephenson TJ, Rees RC: Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 158:2327, 1997
37. Ries C, Kolb H, Petrides PE: Regulation of 92-kD gelatinase release in HL-60 leukemia cells: Tumor necrosis factor-α as an autocrine stimulus for basal-and phorbol ester-induced secretion. Blood 83:3638, 1994
38. Watanabe H, Nakanishi I, Yamashita K, Hayakawa T, Okada Y: Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: Correlation with cellular invasion. J Cell Sci 104:991, 1993
39. Kawashima A, Nakanishi I, Tsuchiya H, Roessner A, Obata K, Okada Y: Expression of matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) induced by tumor necrosis factor-a correlates with metastatic ability in a human osteosarcoma cell line. Virchows Arch 424:547, 1994
40. Okada Y, Tsuchiya H, Shimizu H, Tomita K, Nakanishi I, Sato H, Seiki M, Yamashita K, Hayakawa T: Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha. Biochem Biophys Res Commun 171:610, 1990
41. Lauricella-Lefebre MA, Castronovo V, Sato H, Seiki M, French DL, Merville MP: Stimulation of the 92-kD type IV collagenase promoter and enzyme expression in human melanoma cells. Invasion Metastasis 13:289, 1993
42. Vilcek J, Lee TH: Tumor necrosis factor: New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266:7313, 1991
43. Benbow U, Brinckerhoff CE: The AP-1 site and MMP gene regulation: What is all the fuss about? Matrix Biol 15:519, 1997
44. Overall CM, Wrana JL, Sodek J: Independent regulation of collagenase, 72-kDa progelatinase and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem 264:1860, 1989
45. Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H, Larjava H: Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem 266:11436, 1991
46. Long L, Navab R, Brodt P: Regulation of the Mr 72,000 type IV collagenase by the type I insulin-like growth factor receptor. Cancer Res 58:3243, 1998
47. Migita K, Eguchi K, Kawabe Y, Ichinose Y, Tsukada T, Aoyagi T, Nakamura H: TNF-α-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts. Immunology 89:553, 1996
48. Xia M, Leppert D, Hauser SL, Sreedharan SP, Nelson PJ, Krensky AM, Goetzl EJ: Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J Immunol 156:160, 1996
49. Levesque JP, Leavesley DI, Niutta S, Vadas M, Simmons PJ: Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med 181:1805, 1995
50. Craddock CF, Nakamoto B, Andrews RG, Priestley GV, Papayannopoulou T: Antibodies to VLA4 integrin mobilize long-term repopulating cells and augment cytokine-induced mobilization in primates and mice. Blood 90:4779, 1997
51. Romanic AM, Madri JA: The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J Cell Biol 125:1165, 1994
52. 3. Cell 85:683, 1996
53. Bord S, Homer A, Hembry RM, Reynolds JJ, Compston JE: Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic bone. J Anatomy 191:39, 1997
54. Körbling M, Przepiorka D, Huh YO, Engel H, van Bisen K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659, 1995